Your browser doesn't support javascript.
loading
The role of microRNAs in the development and progression of chemical-associated cancers.
Pogribny, Igor P; Beland, Frederick A; Rusyn, Ivan.
Afiliação
  • Pogribny IP; Division of Biochemical Toxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: igor.pogribny@fda.hhs.gov.
  • Beland FA; Division of Biochemical Toxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR 72079, USA.
  • Rusyn I; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843, USA.
Toxicol Appl Pharmacol ; 312: 3-10, 2016 Dec 01.
Article em En | MEDLINE | ID: mdl-26621330
ABSTRACT
Human exposure to certain natural and man-made chemical carcinogens is one of the major risk factors for cancer development. The effect of chemical carcinogens on genetic and epigenetic alterations and their significance in the development of cancer has been well-established. In contrast, the role of microRNAs (miRNAs) in the etiology of chemical-associated cancers remains relatively unexplored despite extensive reports on changes in miRNA expression upon carcinogen exposure. This review summarizes the current knowledge for the role of miRNAs as drivers of chemical-induced carcinogenesis by bridging the gap between carcinogen exposure and cancer development through functional studies. It also emphasizes the potential for miRNA changes as early indicators of the carcinogenic process, markers for carcinogen exposure, and identification of chemical carcinogenic hazards.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinógenos / MicroRNAs / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinógenos / MicroRNAs / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2016 Tipo de documento: Article